TR-13-2 focuses on environmental controls and monitoring programs for classified areas where manufacturing processes are required to ensure a low bioburden level of the material being produced. Although a comprehensive EM program addresses both viable and nonviable aspects of the facility, this addendum concentrates primarily on the viable aspects as these parameters have a greater potential to impact product and process quality related to bioburden. This document is not intended to address EM programs for traditional aseptic or sterile manufacturing, which are covered in TR-13, nor does it address traditional nonsterile dosage forms.
Original price was: $325.00.$162.00Current price is: $162.00.
Technical Report No. 13-2 Fundamentals of an Environmental Monitoring Program Annex 1: Environmental Monitoring of Facilities Manufacturing Low Bioburden Products
Parenteral Drug Association , 11/01/2020
Pages: 29










